INCOME TAXES (Tables)

12 Months Ended

Feb. 28, 2021

Income Tax Disclosure [Abstract]

Schedule of Income Before Income Taxes

Our income (loss) before income taxes and equity in net loss of affiliate consists of the following (in thousands):

	Year Ended February 28/29,
	2021			2020			2019
Domestic	$	(16,964	)	$	(31,381	)	$	24,359
Foreign		(3,632	)		813			2,488
Total income (loss) before income taxes and equity in net loss of affiliate	$	(20,596	)	$	(30,568	)	$	26,847

Components of Income Tax Benefit (Provision)

The components of income tax benefit (provision) consists of the following (in thousands):

	Year Ended February 28/29,
	2021			2020			2019
Current:
Federal	$	-		$	-		$	404
State		40			(273	)		(256	)
Foreign		(602	)		(1,629	)		(62	)
Total current		(562	)		(1,902	)		86
Deferred:
Federal		(59	)		(12,852	)		(2,621	)
State		(18	)		(10,645	)		(1,295	)
Foreign		78			4,945			4,442
Total deferred		1			(18,552	)		526
Income tax benefit (provision)	$	(561	)	$	(20,454	)	$	612

Reconciliation of Effective Income Tax Benefit (Provision)

The income tax benefit (provision) differs from the amount obtained by applying the statutory rate as follows (in thousands):

	Year Ended February 28/29,
	2021			2020			2019
Income tax benefit (provision) at U.S. statutory federal rate	$	4,325		$	6,420		$	(5,638	)
State income tax benefit (provision), net of federal income tax effect		602			117			(1,412	)
Foreign taxes benefit (provision)		900			(50	)		(31	)
U.S. taxes on foreign income		(306	)		(571	)		-
Valuation allowance reductions (increases)		(5,825	)		(27,726	)		5,915
Research and other tax credits		1,322			2,594			1,658
Tax benefits on vested and exercised equity awards		(851	)		(606	)		758
Non-deductible expenses		(655	)		(697	)		(229	)
Other, net		(73	)		65			(409	)
Total income tax benefit (provision)	$	(561	)	$	(20,454	)	$	612

Schedule of Net Deferred Tax Income Assets

The components of net deferred income tax assets for income tax purposes are as follows (in thousands):

	February 28/29,
	2021			2020
Net operating loss carryforwards	$	27,194		$	22,500
Depreciation, amortization and impairments		(2,117	)		(5,353	)
Research and development credits		21,917			20,603
Stock-based compensation		2,944			2,556
Other tax credits		2,197			2,172
Capitalized research costs		2,638			3,389
ROU asset		(3,528	)		(5,174	)
Lease liabilities		5,472			7,455
Payroll and employee benefit accruals		1,984			2,077
Allowance for doubtful accounts		1,163			965
Other accrued liabilities		4,743			4,887
Convertible debt		(8,185	)		(9,477	)
Other, net		5,137			3,275
Gross deferred tax assets		61,559			49,875
Valuation allowance		(56,848	)		(45,560	)
Net deferred tax assets	$	4,711		$	4,315
Reported as:
Deferred tax assets	$	4,889		$	4,437
Deferred tax liabilities		(178	)		(122	)
Net deferred tax assets	$	4,711		$	4,315

Summary of Unrecognized Tax Benefits

	Year Ended February 28/29,
	2020			2019			2018
Gross amounts of unrecognized tax benefits as of the beginning of the period	$	2,172		$	3,201		$	1,029
Increases related to prior period tax positions		-			-			2,241
Decreases related to prior period tax positions		(422	)		(1,029	)		(69	)
Gross amounts of unrecognized tax benefits as of the end of the period	$	1,750		$	2,172		$	3,201